Clinical Trial Update: Study of the Combination Therapy of Rt-PA and Eptifibatide to Treat Acute Ischemic Stroke [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the combination of alteplase (rt-PA) and eptifibatide for acute ischemic stroke has completed, with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cerebral Infarction
• Stroke

Drugs mentioned

• Activase (alteplase)
• Integrilin (Eptifibatide)

Snippet

Sponsor: University of Cincinnati | Conditions: Ischemic Stroke, Stroke | Phase 2 | Status: COMPLETED | Results posted: 2014-03-17